seen from United States
seen from United States
seen from United States
seen from Belgium
seen from United States
seen from United States
seen from United States
seen from United States
seen from Bosnia & Herzegovina
seen from United States
seen from United States
seen from United Kingdom
seen from China
seen from United States
seen from Italy
seen from Maldives
seen from United States
seen from United States
seen from South Korea
seen from United States
Top 20 predictions for stem cells & regenerative medicine in 2018
Every year I look into my stem cell crystal ball and make predictions for our field including regenerative medicine.
Well, I don’t really look into a crystal ball, but I try to use a combination of what I’m hearing through the grapevine, stuff I’m reading, some info that is not yet in the public domain, and common sense to make predictions.
Today’s post has my 20 predictions for next year, 2018.…
View On WordPress
Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte
Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte
It’s a difficult, but very important road to conclusively prove that an investigational stem cell therapy is both safe and effective in order to get final approval FDA or equivalents in other countries. For this reason, it is beneficial to highlight even small, but positive steps forward including encouraging pre-clinical data.
ViaCyte’s VC-01 post-implant
Today I’m doing a review of stem cell…
View On WordPress
